DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This is a pilot, phase 2, prospective, comparative study to evaluate the safety and efficacy
of the combination of Levulan® Kerastick® for Topical Solution and blue light illumination
using the BLU-U® Blue Light Photodynamic Therapy Illuminator (LevulanPDT).
The study hypothesis is that post solid organ transplantation patients, highly susceptible to
non-melanoma skin cancer, can be treated safely and effectively through clinical cyclic
application of PDT, lessening morbidity and possible mortality for this immunosuppressed
patient population.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Medical Dermatology Specialists University of Arizona